Literature DB >> 7543648

Double in situ hybridization study on coexistence of mu-, delta- and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia.

M Minami1, K Maekawa, K Yabuuchi, M Satoh.   

Abstract

Coexistence of the mRNA for each subtype of opioid receptor (OPR) with the mRNA for preprotachykinin A (PPTA), a precursor protein of substance P (SP), in the rat dorsal root ganglia was examined by double in situ hybridization technique. About 90% and 30% of PPTA mRNA-positive neurons expressed mu- and kappa-OPR mRNAs at high level, respectively. However, only about 3% of PPTA mRNA-positive neurons expressed delta-OPR mRNA at high level. These results suggest that mu- and kappa-OPRs exist on most of and a part of the primary afferent terminals containing SP, respectively. On the other hand, among the neurons which highly expressed mu-, delta- or kappa-OPR mRNA, PPTA mRNA was not expressed in about 58%, 95% or 24% of those neurons, respectively. These findings suggest the possibility that OPRs co-exist with other neurotransmitters and/or neuromodulators than SP in the primary afferent neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543648     DOI: 10.1016/0169-328x(94)00290-u

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  28 in total

1.  Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain.

Authors:  Benjamin Storek; Matthias Reinhardt; Cheng Wang; William G M Janssen; Nina M Harder; Michaela S Banck; John H Morrison; Andreas S Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-22       Impact factor: 11.205

Review 2.  Peripheral mechanisms of pain and analgesia.

Authors:  Christoph Stein; J David Clark; Uhtaek Oh; Michael R Vasko; George L Wilcox; Aaron C Overland; Todd W Vanderah; Robert H Spencer
Journal:  Brain Res Rev       Date:  2008-12-31

3.  Spinal μ and δ opioids inhibit both thermal and mechanical pain in rats.

Authors:  Audrey Normandin; Philippe Luccarini; Jean-Louis Molat; Louis Gendron; Radhouane Dallel
Journal:  J Neurosci       Date:  2013-07-10       Impact factor: 6.167

4.  Peripheral δ-opioid receptors attenuate the exercise pressor reflex.

Authors:  Anna K Leal; Katsuya Yamauchi; Joyce Kim; Victor Ruiz-Velasco; Marc P Kaufman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-09       Impact factor: 4.733

Review 5.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 6.  Opioid receptor trafficking and interaction in nociceptors.

Authors:  X Zhang; L Bao; S Li
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

7.  A substance P-opioid chimeric peptide as a unique nontolerance-forming analgesic.

Authors:  S E Foran; D B Carr; A W Lipkowski; I Maszczynska; J E Marchand; A Misicka; M Beinborn; A S Kopin; R M Kream
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 8.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

9.  IL-4 induces M2 macrophages to produce sustained analgesia via opioids.

Authors:  Melih Ö Celik; Dominika Labuz; Jacqueline Keye; Rainer Glauben; Halina Machelska
Journal:  JCI Insight       Date:  2020-02-27

10.  Delta opioid receptors presynaptically regulate cutaneous mechanosensory neuron input to the spinal cord dorsal horn.

Authors:  Rita Bardoni; Vivianne L Tawfik; Dong Wang; Amaury François; Carlos Solorzano; Scott A Shuster; Papiya Choudhury; Chiara Betelli; Colleen Cassidy; Kristen Smith; Joriene C de Nooij; Françoise Mennicken; Dajan O'Donnell; Brigitte L Kieffer; C Jeffrey Woodbury; Allan I Basbaum; Amy B MacDermott; Grégory Scherrer
Journal:  Neuron       Date:  2014-02-27       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.